ArticleTherapeutic advances in medical oncology2026
Comparative efficacy and safety of NALIRIFOX versus other first-line chemotherapy regimens in metastatic pancreatic ductal adenocarcinoma: a retrospective study.
Yuqi Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.